FDA Clearance Tracker · P060011-S045
RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X
Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 24, 2026
Approved
Time to decision
224 days
Received Feb 12, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P060011-S045
- Device name
- RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X
- Applicant
- Rayner Intraocular Lenses , Ltd.
- Applicant location
- Hove, E. Sussex
- Received
- Feb 12, 2026
- Decided
- Sep 24, 2026
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P060011
Device type
- Device type
- Lens, multifocal intraocular (MFK)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the RayOne Galaxy (RAO605G) and the RayOne Galaxy Toric (RAO615X). RayOne Galaxy (Model RAO605G) is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed.The IOL mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity to a monofocal IOL.RayOne Galaxy is intended for implantation in patients with less than 1.00 diopter of pre-existing corneal astigmatism. The RayOne injection system is used to fold and assist in inserting the IOL into the eye.RayOne Galaxy Toric (Model RAO615X) is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed.The IOL mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity to a monofocal IOL.In addition, RayOne Galaxy Toric is intended to provide reduction of residual refractive astigmatism in patients with corneal astigmatism greater than or equal to 1.03 diopter, up to 3.07 diopter. The RayOne injection system is used to fold and assist in inserting the IOL into the eye.
Source documents
Other decisions for Rayner Intraocular Lenses , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RayOne EMV ToricPMA supplement
P060011-S039 · Decided Oct 9, 2025 · 206 days after receipt · Panel Track
Device type: intraocular lens (HQL) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.